KMV Narayana Rao appointed as Vice President - ARD at NATCO Research Centre

Published On 2024-06-15 06:26 GMT   |   Update On 2024-06-15 06:26 GMT

Hyderabad: Through a recent BSE filing, Natco Pharma has informed that K.M.V. Narayana Rao has been appointed as Vice President - ARD at NATCO Research Centre w.e.f. 12th June, 2024.

K.M.V. Narayana Rao has 28+ years of experience in Analytical R&D in APl's and NCE's, Key contributor to primary registration documents in GxP environment (CMC, IND, ANDA, CEP, DMF). He earlier worked as Associate Vice President (Head Analytical) at M/s. Aragen Life Sciences Private Limited (formerly GVKBIO) Hyderabad, India from 2015. He holds Ph.D (Analytical Chemistry) and M.Sc. Physical Chemistry from Andhra University, Visakhapatnam, India.

Advertisement

Read also: Migraine drug: Natco Pharma submits application for generic version of Rimegepant Sulfate tablet with USFDA

Natco Pharma Limited was incorporated in Hyderabad in the year 1981 with an initial investment of INR 3.3 million. With a modest beginning of operations as a single unit with 20 employees, Natco today has eight manufacturing facilities spread across India with modern research laboratories, capabilities in New Drug Development, etc.

Read also: Natco Pharma invests around US$ 2 million in Cellogen Therapeutics






Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News